Citations

Institution: Mayo Clinic Clear

Showing 10 of 108083 citations.

Modifying inhibitor specificity for homologous enzymes by machine learning
Gozlan, Dor S. , Meiri, Reut , Shapira, Gili, Radisky, Evette S. , Orenstein, Yaron , Papo, Niv , Coban, Matt , Radisky, Evette S , Orenstein, Yaron , Papo, Niv , Shapira, Gili

The FEBS Journal | September 6, 2025 | Volume: 293 | Issue: 4 | Pages: 1007-1023

10.1111/febs.70249 | PMID 40912922 Get It

Selective inhibitors are essential for targeted therapeutics and for probing enzyme functions in various biological systems. The two main challenges in identifying such protein‐based inhibitors lie in the extensive experimental effort required, including the generation of large libraries, and in tailoring the selectivity of inhibitors to enzymes with homologous structures. To address these challenges, machine learning (ML) is being used to improve protein design by training on targeted libraries and identifying key interface mutations that enhance affinity and specificity. However, such ML‐based methods are limited by inaccurate energy calculations and difficulties in predicting the structural impacts of multiple mutations. Here, we present an ML‐based method that leverages HTS data to streamline the design of selective protease inhibitors. To demonstrate its utility, we applied our new method to find inhibitors of matrix metalloproteinases (MMPs), a family of homologous proteases involved in both physiological and pathological processes. By training ML models on binding data for three MMPs (MMP‐1, MMP‐3, and MMP‐9), we successfully designed a novel N‐TIMP2 variant with a differential specificity profile, namely, high affinity for MMP‐9, moderate affinity for MMP‐3, and low affinity for MMP‐1. Our experimental validation showed that this novel variant exhibited a significant specificity shift and enhanced selectivity compared with wild‐type N‐TIMP2. Through molecular modeling and energy minimization, we obtained structural insights into the variant's enhanced selectivity. Our findings highlight the power of ML‐based methods to reduce experimental workloads, facilitate the rational design of selective inhibitors, and advance the understanding of specific inhibitor–enzyme interactions in homologous enzyme systems.
Minimal changes in excitation-contraction coupling in spastic human muscle
Wang, Zheng , Hoffman, E. Matthew , Litchy, William J. , Rhee, Peter C. , Lieber, Richard L. , Hoffman, Ernest Matthew , Rhee, Peter C , Kaufman, Kenton R , Lieber, Richard L , Shin, Alexander Y. , Kaufman, Kenton R.

Journal of Neurophysiology | September 6, 2025 | Volume: 134 | Issue: 4 | Pages: 1069-1074

10.1152/jn.00274.2025 | PMID 40912898 Get It

This study presents the first in vivo intraoperative measurement of the kinetic properties of spastic human muscle. Despite slower relaxation in spastic biceps, the force-frequency relationship was similar to that of the healthy gracilis muscle. This suggests that spasticity does not substantially alter frequency-dependent force summation, possibly due to similar fiber-type compositions and limited changes in calcium handling or myosin isoforms in human spastic muscle.
Hemodynamic Effects of Guideline-Based Sedation in Mechanically Ventilated Adults: A Multicenter Observational Analysis
Heybati, Kiyan , Xie, Guozhen , Deng, Jiawen , Yadav, Hemang , Yadav, Hemang , Deng, J , Walkey, Allan J. , Gajic, Ognjen

Critical Care Explorations | September 5, 2025 | Volume: 7 | Issue: 9 | Pages: e1313

10.1097/cce.0000000000001313 | PMID 40911767 Get It

IMPORTANCE: Propofol is a first-line sedative for adults receiving invasive mechanical ventilation (IMV). However, it can contribute to hemodynamic instability, especially during intubation. The magnitude, timing, risk factors, and variability of sedation-associated mean arterial pressure (MAP) changes remain poorly characterized in ICU settings. OBJECTIVES: To quantify MAP changes following propofol sedation, identify risk factors for hemodynamic instability, and characterize associated interventions. DESIGN: Retrospective cohort study. The primary outcome was MAP change within 2 hours following sedation. Secondary outcomes included vasopressor use and hypotension (MAP ≤ 60 mm Hg). Mixed-effects modeling was used to account for individual patient differences. SETTING AND PARTICIPANTS: Adults (≥ 18 yrs old) who required IMV and received greater than or equal to 6 consecutive hours of propofol infusion, between May 5th, 2018, and July 31st, 2024, in 11 ICUs across the Mayo Clinic, spanning 5 hospitals in 4 states. MAIN OUTCOMES AND MEASURES: The primary outcome was the change in MAP within 2 hours following the initiation of propofol-based sedation. RESULTS: Across 16,418 patients, 25.2% were on vasopressors before sedation initiation. Among the remaining 12,281 patients, 40.3% required vasopressors and 7.7% experienced hypotension within 2 hours of sedation. Propofol-based sedation was associated with a MAP reduction within the first 30 minutes (–6.58 mm Hg; 95% CI, –6.85 to –6.32; p < 0.001). There was substantial interpatient variability in both baseline MAP, and MAP decline after sedation (9.5 and 40.9% between-patient differences, respectively). Higher Sequential Organ Failure Assessment (SOFA) scores (–0.31 mm Hg/point), older age (–0.04 mm Hg/yr), and male sex (–0.47 mm Hg) were associated with lower MAP. Patients with higher illness severity experienced progressively greater MAP decline over time (–0.20 mm Hg/hr/SOFA point; p < 0.001). CONCLUSIONS AND RELEVANCE: Propofol-based sedation was associated with clinically significant hemodynamic effects requiring intervention in the early post-intubation period. The marked interpatient variability in hemodynamic responses highlights the importance of personalized management approaches, including risk stratification based on age, sex, and illness severity.
Mean Body Mass Index Does Not Increase or Decrease at 10 Years After Primary Total Hip or Knee Arthroplasty
Karczewski, Daniel , Fruth, Kristin M. , Bedard, Nicholas A. , Berry, Daniel J. , Abdel, Matthew P. , Seward, Michael W , Fruth, Kristin M , Berry, Daniel J , Abdel, Matthew P , Bedard, Nicholas A

Journal of Bone and Joint Surgery | September 5, 2025 | Volume: 107 | Issue: 21 | Pages: 2389-2395

10.2106/jbjs.24.01401 | PMID 40911649 Get It

Background: Although patients often aim to lose weight after total hip arthroplasty (THA) or total knee arthroplasty (TKA), long-term changes in body mass index (BMI) are unknown. We analyzed BMI at 2, 5, and 10 years after primary THA and TKA and determined predictors of BMI change. Methods: We identified patients who underwent primary THA or TKA for osteoarthritis between 2001 and 2011 and had a BMI at surgery and at 2, 5, and 10 years postoperatively. This resulted in 763 patients (310 who underwent THA and 453 who underwent TKA). The mean patient age was 66 years, and 60% of patients were female. BMI changes were analyzed with repeated-measures analysis of variance. Multinomial logistic regression determined predictors of BMI change. Results: Following THA, the mean BMI increased from 30.3 kg/m 2 at surgery to 30.9 kg/m 2 at both 2 years (p = 0.003) and 5 years (p = 0.002). Following TKA, the mean BMI increased from 32.7 kg/m 2 at surgery to 33.1 kg/m 2 at both 2 years (p = 0.053) and 5 years (p = 0.040). By 10 years, the mean BMI was 30.6 kg/m 2 (p = 0.453) for patients undergoing THA and 32.6 kg/m 2 (p = 0.947) for patients undergoing TKA, similar to the BMIs at surgery. At 10 years, 27% of patients who underwent THA and 30% of patients who underwent TKA had a BMI decrease of >5%, whereas 30% of patients who underwent THA and 32% of patients who underwent TKA had a BMI increase of >5%. Female sex among patients who underwent THA increased the odds of a >5% BMI increase at 10 years (odds ratio [OR], 2.1; p = 0.006). Older age among patients who underwent TKA decreased the odds of a >5% BMI increase at 10 years (OR per year, 0.95; p < 0.001). Conclusions: Although most patients experienced a BMI change of >5% at 10 years, the mean BMI did not meaningfully change 2, 5, or 10 years after THA or TKA. Arthroplasty should not be viewed as a gateway to BMI improvement for patients overall, but female sex and older age may predict clinically important weight changes 10 years after arthroplasty. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
Retinal gene therapy using epiretinal AAV-containing fibrin hydrogel implants
Scruggs, Brittni A. , Berger, Aubrey , Knudsen, Travis, Kopp, Francesca N., Hill, Matthew, Trncic, Emma , Anderson, Kjersten, Iezzi, Raymond , Marmorstein, Alan D. , Scruggs, Brittni A , Marmorstein, Alan D , Kopp, Francesca N., Anderson, Kjersten

Science Advances | September 5, 2025 | Volume: 11 | Issue: 36 | Pages: No page available

10.1126/sciadv.adv7922 | PMID 40911667 Get It

Subretinal injection of adeno-associated virus (AAV) is generally more efficacious and less inflammatory than intravitreal injection for retinal gene therapy. However, adverse events (e.g., chorioretinal atrophy) have been reported in many patients receiving subretinal injection of Luxturna (voretigene neparvovec-rzyl) and experimental gene therapies. Subretinal injection confines transduction to the treated area. To address this, we manufactured high-concentration fibrin hydrogels encapsulating AAV2–green fluorescent protein (AAV2- GFP ). Gels had homogeneous AAV distribution, desired mechanical properties, and retained infectivity. Epiretinal placement of fibrin–AAV2- GFP ( n = 11) was compared to subretinal ( n = 5) and intravitreal AAV2- GFP injection ( n = 3). The subretinal group exhibited inconsistent retinal pigment epithelium (RPE) transduction restricted to the injection region with severe atrophy in two cases. The intravitreal group had weak transduction and inflammation. In contrast, epiretinal hydrogels degraded within days and led to broad transduction of RPE without atrophy or inflammation. This technology could advance gene therapy for retinal degenerations and other ocular or systemic disorders.
American Board of Internal Medicine’s Pilot Pathway to Board Eligibility for International Medical Graduates
Daoud, Ahmed , Kamal, Ahmed , Barakat, Munsef, Naeem, Ubaid, Bakhaty, Omar, Herberth, Johann , Cheungpasitporn, Wisit , Campbell, Ruth , Fülöp, Tibor , Soliman, Karim , Cheungpasitporn, Wisit , Fülöp, Tibor , Soliman, Karim M , Naeem, Ubaid

Clinical Journal of the American Society of Nephrology | September 5, 2025 | Volume: 20 | Issue: 12 | Pages: 1814-1817

10.2215/cjn.0000000823 | PMID 40911355 Get It

Prospective comparison of ultra-high-resolution photon-counting detector CT coronary angiography versus conventional CT
McCollough, Cynthia H. , Davis, Ann A., Weber, Nikkole M. , Kasten, Holly J., Melka, Elnata F., Rajendran, Kishore , Leng, Shuai , Davis, Aeden K, Leng, Shuai , McCollough, Cynthia H , Rajendran, Kishore , Carter, Rickey E.

British Journal of Radiology | September 5, 2025 | Volume: 99 | Issue: 1177 | Pages: 73-82

10.1093/bjr/tqaf220 | PMID 40911287 Get It

Abstract Objectives Determine differences in quantitative stenosis severity measurements for ultra-high-resolution (UHR) photon-counting detector (PCD) coronary CT angiography (cCTA) relative to energy-integrating detector (EID) cCTA in a large patient cohort. Methods Adult participants seen between November 2022 and March 2023 underwent a clinical dual-source EID-CT cCTA and a research dual-source PCD-CT cCTA on the same day. Percent diameter stenosis (PDS) was measured, and stenosis severity was assigned based on the PDS of the most severe lesion per patient to determine a coronary artery disease reporting and data system (CAD-RADS) score. Agreement between EID-CT and PCD-CT for PDS and CAD-RADS was determined. Results A total of 112 participants were enrolled, yielding 82 subjects with at least 1 stenosis at PCD-CT (mean age, 68.0 ± 10.8 years; 69.5% [57/82] males). A total of 177 paired stenoses were quantified. The percent decrease in mean PDS from PCD-CT (24.3%) to EID-CT (29.4%) was 17.3% (median difference in PDS: −5.0%, 95% CI: −5.7% to −4.0%). The assigned CAD-RADS score changed in 31/82 subjects. In 11/31 subjects, the most severe stenosis was missed at EID-CT due to partial volume averaging of a small calcification, yet PCD clearly identified stenosis at those locations. In 20/31 subjects, the CAD-RADS score decreased at PCD-CT due to the decreased calcium blooming resulting from the improved spatial resolution. Conclusions UHR PCD cCTA decreases quantitative measures of stenosis severity when a stenosis is identified at EID, leading to decreases in CAD-RADS assignments. Advances in knowledge With its improved spatial resolution, PCD-CT identifies stenoses missed on EID-CT.
Empowering Early Recovery: The Role of Impella 5.5 in Takotsubo Cardiomyopathy Complicated by Cardiogenic Shock
Desai, Aarti , Ruiz, Jose , Shapiro, Anna Bovill , Klingbeil, R. , Goswami, Rohan , Shapiro, Anna , Klingbeil, Rebecca , Goswami, Rohan M , Desai, Aarti , Martin, Archer Kilbourne

Journal of Clinical Medicine | September 5, 2025 | Volume: 14 | Issue: 17 | Pages: 6278

10.3390/jcm14176278 | PMID 40944037 Get It

Introduction: Takotsubo cardiomyopathy (TCM), also known as stress cardiomyopathy or Broken Heart Syndrome, is a reversible, transient state of myocardial dyskinesis and apical ballooning. Infrequently, TCM may progress to severe life-threatening complications such as cardiogenic shock. Early mechanical circulatory support (MCS) is crucial to myocardial recovery in these cases. We present one of the first cases of TCM successfully treated with the advanced micro-axial minimally invasive Impella 5.5 with SmartAssist MCS device. Case Presentation: A female in her late 70s with a history of hypothyroidism, atrial fibrillation post-ablation, and cholelithiasis was referred to our facility for an elective cholecystectomy. Post-anesthesia induction with propofol 2.1 mg/kg (140 mg bolus), she became bradycardic and hypotensive, eventually leading to asystole, requiring CPR and termination of the procedure. Echocardiography revealed a left ventricular ejection fraction (LVEF) of 24% with mid-ventricular akinesis and apical ballooning with mild mitral regurgitation, suggesting the diagnosis of TCM. Cardiac catheterization showed RA 20 and mean PA 42 mmHg. Lactate was 18.7 mmol/L and LDH 1776 U/L, suggesting progressive shock. Continuous epinephrine 0.1 mcg/kg/min and norepinephrine 0.06 mcg/kg/min were titrated for BP 97/58, and she was initially supported with the Impella CP device. Despite aggressive efforts, rising LDH levels and increased vasopressor needs indicated inadequate organ perfusion, requiring an upgrade to Impella 5.5. Impella 5.5 support for 11 days led to impressive myocardial recovery, leading to reductions, and eventual discontinuation, of inotropes and vasopressors. Post-Impella 5.5 explantation, her LVEF was 59–65% and she was discharged with Mobile Cardiac Outpatient Telemetry (MCOT) monitoring for her arrhythmias and reinitiation of guideline-directed medical therapies (GDMTs) for her comorbidities. Her 2-month follow-up shows sustained LVEF greater than 45% with functional improvements. Conclusions: Early escalation within 24 h of Impella CP to Impella 5.5 provided stabilization of cardiometabolic shock, preventing end-organ damage, allowing recovery of native heart function while maintaining ambulatory status, and allowing for optimizing medical therapy. It presents a safe, minimally invasive, and cost-effective intervention in TCM cases refractory to GDMT or when additional time is needed for decision-making in cases presenting with CS.
Klebsiella pneumoniae Invasive Syndrome without Liver Abscess: A Case Report
Dhamelia, Parth M. , Mokariya, Dipak R., Anand, Jaspreet Singh , Chitale, Rohit , Oring, Justin , Anand, Jaspreet Singh

American Journal of Case Reports | September 5, 2025 | Volume: 26 | Issue: No issue available | Pages: No page available

10.12659/ajcr.949163 | PMID 41084227 Get It

Evaluating Breast Cancer Intravoxel Incoherent Motion MRI Biomarkers across Software Platforms
Sigmund, Eric E. , Cho, Gene Y., Basukala, Dibash , Sutton, Olivia M. , Horvat, João V. , Mikheev, Artem , Rusinek, Henry , Gilani, Nima , Li, Xiaochun , Babb, James S , Pinker, Katja , Moy, Linda , Thakur, Sunitha B , Sigmund, Eric , Rusinek, Henry , Babb, James S. , Goldberg, Judith D. , Moy, Linda

Radiology: Imaging Cancer | September 5, 2025 | Volume: 7 | Issue: 5 | Pages: No page available

10.1148/rycan.240115 | PMID 40910883 Get It

Intravoxel incoherent motion MRI parameters derived from two software packages demonstrated diagnostic value for breast cancer, with multivariable combinations of histogram metrics achieving high diagnostic accuracy.